Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
(2024, August 21)
doi:10.1038/s41591-023-02634-8 Cai M, Choi T, Xie Y, Al-Aly Z
A similar medication called Wegovy with the same active ingredient, semaglutide, is approved for weight loss and obesity
Popular branded versions include: Ozempic (semaglutide) : Approved for Type 2 diabetes Wegovy (semaglutide) : Approved for chronic weight management Mounjaro (tirzepatide) : Newer dual-action drug also making waves GLP-1 drugs are typically injected weekly and have been shown to reduce blood sugar levels and body weight dramatically
CEO, Matt Osborn, says that In todays telehealth landscape, the ability for patients to access an initial clinical assessment, a tailored prescription, and an ongoing, reliable source of safe, bespoke, and titrated medication that supports their long-term health strategy should be available for everyone
